乐普生物科技股份有限公司（下称“乐普生物科技”，股票代码：02157）于2026年2月5日发布2026年1月股份变动月报。报告期为2026年1月1日至1月31日，公司注册股本及已发行股份数均无变动，股本总额维持不变。
截至2026年1月31日，公司法定注册股本仍为人民币1,804,439,838元，已发行普通股（H股）总数为1,804,439,838股。报告期内未发生新增发行、购回、注销或库藏股变动，也无股份期权及股权激励计划的变动事项。公司确认已符合香港联交所上市规则的最低公众持股量要求。
公告由联席公司秘书李昀轶女士签署。公司表示将持续遵守香港联交所《上市规则》及相关法律法规，确保股本信息披露的真实、准确与合规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.